Hologic Acquires Somatex Medical For $64M To Expand Breast Health Care, European Sales Presence

 
• By Marion Webb
  
Generate a summary of this article
Listen to this article
Beta

Hologic’s acquisition of Somatex Medical will expand its biopsy portfolio and direct channel in Germany.

Scientist analyzing microscope slide at laboratory

Marlborough, MA-based medtech Hologic Inc. said the buy-out of SOMATEX Medical Technologies GmbH, which develops minimally invasive devices for tumor diagnostics, biopsy and interventional specialties, will allow Hologic to strengthen and further expand its breast cancer marker portfolio. It also enhances its sales presence in Europe by expanding its direct channel in Germany and its network of regional and international distributor partners. [Sidebar#MT124744]

“The acquisition of Somatex allows us to expand our biopsy portfolio by providing a suite of market-leading solutions that not...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Deals

Investor Eye: Intuitive Surgical Hops, Skips, And Jumps Into VC

 
• By Barnaby Pickering

When a large medtech company sets up a venture fund, it typically invests in technologies that are adjacent to its pre-existing portfolio. Intuitive Surgical’s approach is different.

test carousel-Medtech

 
• By Saba Afreen

test carousel-Medtech

MI-Business (Free-2): Prison Is the First Mental Health Visit for Many in Spain

 
• By Nabil

Spain has one of the highest incarceration rates in Europe, with 160 individuals imprisoned per 100,000 residents. In 2020, 43,494 people were incarcerated in facilities not managed by regional health authorities — essentially all regions except Catalonia, the Basque Country, and Navarra.

Owkin Teams With AstraZeneca To Develop AI-Based Breast Cancer Prescreening Tool

 
• By Natasha Barrow

Biopharmaceutical giant AstraZeneca has partnered with start-up “unicorn” Owkin to develop an AI-powered tool to prescreen for gBRCA mutations on the basis of morphological features in digitized pathology slides. Built on extensive, high-quality data sourced from the France-based PortrAIt consortium, the AI will help to prioritize patients for further testing, streamlining the diagnostic process, Owkin says.

More from Business

test carousel-Medtech

 
• By Saba Afreen

test carousel-Medtech

test carousel

 
• By Saba Afreen and Krsihna

test carousel-HBW

News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards

This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.